Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that Dr. Gerald Bernstein, M.D., the Company’s Vice-President, Medical Affairs, made two invited oral presentations in respect of Generex Oral-lyn™, the Company’s proprietary oral insulin spray product, at the 9th Scientific Congress of The Lebanese Society of Endocrinology, Diabetes, and Lipids held June 2 - 4, 2006 in Broumana, Lebanon.
